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Mattress and pillow for prone positioning for treatment of obstructive
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Abstract
Conclusion: The new mattress and pillow for prone positioning (MPP) is efﬁcient in reducing the apnoea-hypopnoea index
(AHI) and oxygen desaturation index (ODI) in most patients with obstructive sleep apnoea (OSA), with satisfactory
compliance. Objective: The aim of the present study was to evaluate the effect of the prone body and head sleep position
on severity of disease in patients with OSA after 4 weeks of adaptation to a mattress and pillow facilitating prone positioning.
Methods: Fourteen patients with mild to severe OSA, 11 men and 3 women with a mean AHI of 26 (min, 6; max, 53) and mean
ODI of 21 (min, 6; max, 51) were evaluated. Two polysomnographic (PSG) studies were performed. The ﬁrst PSG study was
without any treatment and the second was after 4 weeks of adaptation to the MPP for prone positioning of the body and the
head. Results: Mean AHI and ODI decreased from 26 and 21 to 8 and 7, respectively (p < 0.001) with treatment. The mean
time spent in the supine position was reduced from 128 to 10 min (p = 0.02) and the prone time increased from 42 to 174 min
(p = 0.02) with the MPP. The mean total sleep time was 390 min during the ﬁrst PSG study night without treatment and
370 min during the second night with the MPP (p = 0.7). Ten patients (71%) reduced their AHI by at least 50% and reached a
value < 10 during treatment. All patients managed to sleep on the MPP for > 4 h per night during the 4-week study.
Keywords: Positional treatment, prone sleep position, lateral sleep position, supine sleep position, non-invasive, conservative,
non-surgical treatment, polysomnography
Introduction
The number and duration of respiratory disturbances
during sleep are inﬂuenced by the body position in
most patients with obstructive sleep apnoea (OSA)
[1]. More than 50% of patients with OSA are con-
sidered to have positional OSA (POSA), a condition
in which the apnoea-hypopnoea index (AHI) is at
least twice as high in the supine position compared
with non-supine positions [2,3]. In approximately
80% of all patients with OSA the AHI is higher in
the supine position compared with the non-supine
positions [2,3].
Many patients with OSA cannot tolerate continu-
ous positive airway pressure (CPAP) or they use it
incidentally [4,5]. Many patients with OSA have
contraindications for using oral devices [6]. Previous
positional therapies for patients with OSA have
focused primarily on avoiding the supine position
and/or sleeping in the lateral position [3,7,8].
One of the ﬁrst described therapies to reduce snor-
ing and to improve OSA was the so-called ‘tennis ball
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technique’. A tennis ball is sewn into the pyjamas or
fastened by a belt to the back of the patient to reduce
the time spent in the supine position [9]. This treat-
ment has been shown to reduce the supine time and to
improve AHI in patients with POSA [9,10]. Due to
the limited compliance with all the variations of the
tennis ball technique, several newer positional meth-
ods have been developed primarily to reduce the time
spent in the supine position [7,11,12].
There is limited experience regarding the effect of
the prone position on severity of OSA [13]. In a
previous study from our research group [14], the
effect of prone positioning of the body and the
head was evaluated in patients with OSA. The
mean AHI and ODI were signiﬁcantly improved in
the prone position, with higher efﬁciency observed in
patients with POSA. The long-term efﬁciency and the
compliance of prone positioning were not assessed.
The aim of the present study was to evaluate the
effect of the prone body and head sleep position on
severity of disease in patients with OSA after 4 weeks
of adaptation to a mattress and pillow facilitating
prone positioning.
Material and methods
Study design and subjects
The patients included were referred to the Depart-
ment of Otorhinolaryngology, Sahlgrenska University
Hospital in Gothenburg, Sweden, due to sleep-
disordered breathing. We recruited 15 patients with
mild to severe OSA [15]. Five patients were treated
with CPAP and one with an oral device at baseline. All
patients underwent two ambulatory polysomno-
graphic (PSG) studies. The ﬁrst of these studies
was without any treatment and the second was with
a mattress and pillow for prone positioning (MPP)
after 4 weeks of adaptation to the treatment at home.
Exclusion criteria were neurologic disease that
might inﬂuence the muscle tonus, heart failure,
uncontrolled high blood pressure, body mass index
(BMI) > 40, age < 18 years and pregnancy. All
patients gave written informed consent to participate
in the study. The patients were enrolled from Decem-
ber 2012 to April 2013.
The study was approved by the Local Medical
Ethics Committee for Clinical Trials, 2011/131-11.
All patients gave written informed consent to partic-
ipate in the study.
Mattress and pillow for prone positioning
The MPP model from the previous study [14] was
used to facilitate prone positioning during sleep. The
MPP consisted of a combination of visco-elastic
(memory) and normal foam (Figure 1).
A T-shaped pillow, with a height of 12 cm and a
width of 40 cm, enabled cheek and forehead support
with a relatively well aerated space for breathing,
allowing for a prone head position. A mattress with
a height of 12 cm, width of 80 cm and length of
120 cm was provided to ensure a comfortable and
stable prone body position during sleep. At the upper
end the mattress had excavations of the sides for
positioning of the arms and anatomical angles in
the shoulders and elbows. The support of the chin
on the mattress was optional (Figure 1).
The MPP could be placed upon a normal mattress
and hence would be compatible with the existing bed
at home. The main purpose of the MPP was to
provide a comfortable prone sleep position. After
lying on the MPP, the temperature-sensitive visco-
elastic material moulded to the body shape, which
helped the subject maintain the prone position during
the night. Although lateral positioning would be pos-
sible, supine positioning was difﬁcult (Figure 2).
Sleep recordings
Ambulatory PSG equipment was used (Embla, Flaga
Medical, Reykjavik, Iceland). The sleep studies
included registration of breathing efforts by chest and
Figure 1. The mattress and pillow for prone positioning (MPP) of
the body and the head with the nose mostly perpendicular to the
underlying bed.
Figure 2. Subject in a prone body and head position with the nose
mostlyperpendiculartotheunderlyingbed(up).Lateral sleepposition
with comfortable placement of the shoulder and the arm (down).
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abdominalmovements,airﬂowandsnoringbyoronasal
ﬂowmetry and thermistor, and body position by a
position sensor that could differentiate between
upright, supine, left, right and prone positions. Heart
rate and oxygen saturation were registered by a ﬁnger
pulse-oximeter. Electroencephalography (EEG)mon-
itoring (sensors C3-A2, O1-A2, O2-A1,
C4-A1 derivations), electro-oculogram (left and right)
and submental electromyogram (EMG) were
recorded.
Data interpretation
The sleep studies were analyzed and scored by an
independent technician blinded to the assignment of
the patients. Sleep efﬁciency, sleep stages and arousals
were scored according to the criteria proposed by the
AmericanAssociationofSleepMedicine (AASM)[15].
The total number of apnoeas and hypopnoeas was
divided by the sleep time, giving the AHI. The oxygen
desaturation index (ODI) was calculated in the same
manner based on the total number of desaturations
divided by the sleep time. The respiratory parameters,
sleep time and the time slept in the supine, lateral and
prone positions were compared for each patient with-
out and with the MPP.
Compliance/side effects
Inspired by the CPAP deﬁnition of compliance [4],
patients with a sleep time < 4 h per night with theMPP
were considered non-compliant to the treatment. An
instruction video was provided for correct positioning
on the MPP and a sleep diary was implemented for
registration of compliance and side effects during
treatment. The Epworth Sleepiness Scale (ESS)
was used for the evaluation of daytime sleepiness
before and after treatment [16].
Statistical analysis
A power analysis was conducted to estimate the
appropriate sample size, using the results from the
previous study [14]. To achieve the observed AHI
improvement of 19 in the previous study, at a conﬁ-
dence level of 95% and a power level of 90%, with an
SD in change score of 13, in a two-sided test, the
sample size would be 8. In view of a higher expected
failure rate at follow-up and to allow for exclusions
and drop-outs, as well as obtaining more exact esti-
mates, a target sample of 15 subjects was set.
Statistical analysis was performed using Stata ver-
sion 13 (StataCorp. 2013, College Station, TX,
USA). Quantitative data are reported as mean
(min, max) in the text and median in the ﬁgures.
Comparison of data between the baseline (without
treatment) and with treatment was carried out using
the paired t test in the case of normally distributed
data and the Wilcoxon matched pairs sign-rank test in
the case of skewed data. McNemar’s test was used to
assess paired proportions. All statistical tests were
two-tailed and conducted at 5% signiﬁcance level.
Results
All 15 patients fulﬁlled the study protocol and slept on
the MPP during 4 weeks. One patient was excluded
from the present results due to failure in registration
of oxygen saturation during the ﬁrst PSG study. The
characteristics of the 14 eligible participants are sum-
marized in Table I. According to the ﬁrst PSG study,
9 of 14 patients (64%) had POSA.
Sleep time
The mean total sleep times during the ﬁrst PSG study
night without treatment and the second night after
4 weeks of adaptation to the MPP were, respectively,
390 (min, 238; max, 537) and 370 min (min, 260;
max, 502) (p = 0.7). The mean sleep efﬁciency was
79% during the ﬁrst night and 74% during the second
night (p = 0.4).
Without treatment the mean times spent in the
supine and lateral positions were, respectively,
128 min (min, 0; max, 299) and 220 min (min, 8;
max, 421). With the MPP, mean supine time
decreased to 10 min (min, 0; max, 63) (p = 0.02),
and the mean lateral time was 186 min (min, 0; max,
380) (p = 0.5). The mean prone time increased from
42 min (min, 0; max, 390) to 174 min (min, 7; max,
300) (p = 0.02) with the MPP. Eleven patients spent
no time in the supine position with the treatment
(Figure 3).
Table I. The characteristics of the 14 eligible patients.
Characteristic Statistic Value
Age (years) Mean (min, max) 51 (31, 70)
Gender Male/female 11 M/3 F
BMI Mean (min, max) 26 (21, 33)
AHI Mean (min, max) 26 (6, 53)
ODI Mean (min, max) 21 (6, 51)
POSA n (%) 9 (64)
Total n 14
AHI, apnoea-hypopnoea index; BMI, body mass index; F,
female; M, male; n, number of patients; ODI, oxygen desaturation
index; POSA, position-dependent sleep apnoea.
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AHI/ODI
The mean AHI and ODI without treatment were
26 (min, 6; max, 53) and 21 (min, 6; max, 51) and
decreased to 8 (min, 1; max, 26) and 7 (min, 1; max,
25), respectively, with theMPP (p < 0.001) (Figure 4).
Eleven patients (79%) achieved an AHI < 10 with the
MPP and 10 patients (71%) reduced the AHI by at
least 50% and reached a value < 10 during treatment.
All patients had a reduction in AHI (Figure 6) and
ODI, even if they did not meet these criteria.
The AHI altered depending on the position
(Figure 5). Without MPP the mean supine AHI
was 52 (min, 14; max, 78) and decreased to
7 (min, 0; max, 38) in the prone position during
the second night with the MPP (p < 0.005) (Figure 5).
The mean AHI in the lateral positions did not alter
signiﬁcantly (from 14 to 12; p = 0.6) regardless of
treatment.
With the MPP the mean SaO2-min increased from
80% (min, 54; max, 91) to 87% (min, 78; max, 93)
(p < 0.05). Without treatment 13 patients (93%) had
SaO2-min < 90%, 9 patients (64%) < 85% and
5 patients (36%) < 80%. With the MPP eight patients
(57%) had SaO2-min < 90%, four patients
(29%) < 85% and one patient (7%) < 80%.
Sleep architecture
The mean rapid eye movement (REM) sleep time
remained at 19% without and with MPP, and non-
signiﬁcant alterations in mean N3 sleep time and
mean sleep efﬁciency were observed.
Questionnaires
Ten of 14 patients returned the ESS questionnaires.
The mean ESS score was reduced from 12 to
9 (p = 0.007). Without treatment seven patients
had an ESS score > 10 and after 4 weeks with the
MPP this number was reduced to three (p < 0.05).
Four patients complained about discomfort in the
back during the ﬁrst week with the MPP. However,
compliance was satisfactory with all the patients using
the MPP > 4 h per night during the 4-week follow-up.
Discussion
The present study shows a beneﬁcial effect of the
prone sleeping position on the severity of disease in
patients with OSA. The mean total AHI and ODI
decreased from 26 and 21 to 8 and 7, respectively,
with the MPP. The mean supine time decreased from
128 to 10 min and the mean prone time increased
from 42 to 174 min with treatment. AHI in the supine
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Figure 4. Distribution of apnoea/hypopnoea index (AHI) and
oxygen desaturation index (ODI) during the ﬁrst polysomnographic
(PSG) study night without treatment (blue) and the second study
with the mattress and pillow for prone positioning (MPP) (red).
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Figure 3. Time (in minutes) spent in each position without and
with the mattress and pillow for prone positioning (MPP).
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Figure 5. Apnoea/hypopnoea index (AHI) distribution without and
with the mattress and pillow for prone positioning (MPP). The
prone AHI without treatment and the supine AHI with MPP are
omitted due to short registration time.
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position was 52 without treatment and AHI in the
prone position was 7 with the MPP.
Twelve patients (86%) reduced their baseline AHI
by > 50%, 11 patients (79%) achieved an
AHI < 10 and 8 patients (57%) an AHI £ 5 with
the MPP (Figure 6). This was achieved with no
disruption of the sleep architecture judged by PSG.
Compliance was satisfactory, with all the patients
completing the study with sleep time of > 4 h per night
with the MPP. At baseline, 6 of 15 patients were
under treatment with either CPAP or an oral device.
At the end of the study, 14 patients (93%) wished to
continue with the MPP. One patient was excluded
from the presented results due to failure in the record-
ing of oxygen saturation during the ﬁrst PSG study
night. This patient had an AHI of 17 without theMPP
during the PSG screening night. AHI was 1 with the
MPP and the patient chose also to continue with the
MPP. Five of six patients with a previously initiated
OSA treatment preferred to continue with the MPP,
while one patient chose to go back to the previous
treatment with CPAP at the end of the study.
The patients were encouraged to supply us with
feedback regarding possible alteration in the MPP to
satisfy their personal preferences. Two patients
desired a shorter mattress for partial body support
and eight patients a longer and wider mattress for full
body support. Five patients desired a softer mattress.
Previous trials regarding patients with respiratory
distress syndrome and acute respiratory failure indi-
cate improved oxygenation and reduced mortality
when patients are nursed in the prone position com-
pared with the supine position [17–19]. Our observa-
tions have shown that prone positioning with theMPP
reduced the mean ODI from 21 to 7 and increased the
mean SaO2-min from 80% to 87%.
A limitation in the present study was the lack of
monitoringofthepositionofthehead.Inanearlierstudy,
van Kesteren et al. found that the occurrence of OSA
dependsnotsolelyonthepositionofthetrunkbutalsoon
the position of the head [20]. According to our observa-
tions in a previous study, the head position is important
for the effect on severity of disease [14]. In the present
study one patient had a prone sleep time of 390min and
anAHIof23without treatment.DuringthesecondPSG
studywiththeMPPtheAHIwas improvedto8,probably
due to prone positioning of the head.
Humans seems to be one of the few mammals
preferring the supine sleep position and also one of
the few vertebrates with observed sleep apnoea. Based
on our observations, sleeping in the prone position
reduces the tendency towards airway collapse and
improves respiration in patients with OSA. Future
studies should assess the long-term compliance and
possible side effects of prone positioning.
Conclusions
Prone positioning with the MPP improved AHI
and ODI in patients with OSA, with satisfactory
compliance during the 4-week follow-up. Further
studies are needed to assess the long-term compliance
and efﬁciency of this novel method.
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Figure 6. Individual apnoea/hypopnoea index (AHI) during the
ﬁrst polysomnographic (PSG) study night without treatment and
the second night with the mattress and pillow for prone positioning
(MPP).
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